Laborie Medical Technologies Corp., a diagnostic and therapeutic medical technology company, announced the launch of the alpHaONE system which is designed to diagnose gastroesophageal reflux disease (GERD) and offers up to 96 hours of monitoring data.
GERD is a chronic medical condition caused by the flow of contents from the stomach upwards into the esophagus resulting in both symptoms and complications. It is estimated that 20% of the U.S. population suffers from GERD with the most common symptoms being heartburn and regurgitation1.
The alpHaONE solution features an ergonomic and compact design, enlarged and easy-to-press buttons, and fail-safe capsule delivery system that protects the patient’s esophagus, the company says.
“alpHaONE is a patient-centric system that allows for comfortable monitoring and accurate, reliable data, fulfilling the needs of both patients and healthcare providers to diagnosis GERD,” says Rhett Klein, VP of sales and marketing for Laborie’s GI Business Unit. “Our primary objective has always been to provide solutions that elevate patient outcomes and enhance their overall experience and we look forward to launching this product.”
The comprehensive software application incorporated in the alpHaONE system consists of a Virtual Instruction Program, which allows for effortless navigation. In addition, user-customizable symptom buttons and automatic pH data analysis ensure a seamless user experience.
References
1. Acid Reflux: What is GERD? https://gi.org/topics/acid-reflux/
